Bailard’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89M | Sell |
3,601
-433
| -11% | -$227K | 0.04% | 248 |
|
|
2025
Q1 | $2.56M | Sell |
4,034
-9,388
| -70% | -$5.95M | 0.07% | 206 |
|
|
2024
Q4 | $9.56M | Buy |
13,422
+1,236
| +10% | +$880K | 0.24% | 95 |
|
|
2024
Q3 | $12.8M | Buy |
12,186
+98
| +0.8% | +$103K | 0.33% | 72 |
|
|
2024
Q2 | $12.7M | Sell |
12,088
-56
| -0.5% | -$58.9K | 0.35% | 64 |
|
|
2024
Q1 | $11.7M | Buy |
12,144
+41
| +0.3% | +$39.5K | 0.32% | 75 |
|
|
2023
Q4 | $10.6M | Sell |
12,103
-31
| -0.3% | -$27.2K | 0.31% | 74 |
|
|
2023
Q3 | $9.99M | Buy |
12,134
+294
| +2% | +$242K | 0.33% | 65 |
|
|
2023
Q2 | $8.51M | Buy |
11,840
+2,486
| +27% | +$1.79M | 0.3% | 76 |
|
|
2023
Q1 | $7.69M | Buy |
9,354
+284
| +3% | +$233K | 0.28% | 84 |
|
|
2022
Q4 | $6.54M | Buy |
9,070
+207
| +2% | +$149K | 0.25% | 92 |
|
|
2022
Q3 | $6.11M | Buy |
8,863
+2,732
| +45% | +$1.88M | 0.25% | 91 |
|
|
2022
Q2 | $3.62M | Buy |
6,131
+5,831
| +1,944% | +$3.45M | 0.14% | 136 |
|
|
2022
Q1 | $210K | Buy |
+300
| New | +$210K | 0.01% | 662 |
|
|
2016
Q1 | – | Sell |
-1,000
| Closed | -$543K | – | 332 |
|
|
2015
Q4 | $543K | Buy |
+1,000
| New | +$543K | 0.24% | 134 |
|